Number of Shares
3.22 Mil
Current Holdings Value*
$24.34 Mil
% of Portfolio
8.72%
Total Estimate Gain
$-12.81 Mil
% of Total Estimate Gain
-31.40%

Lynx1 Capital Management LP's Cullinan Therapeutics Inc Holding Summary

As of 2025-03-31, Lynx1 Capital Management LP held 3.22 Mil shares of Cullinan Therapeutics Inc(CGEM), totaling $24.34 Mil. This investment constitutes 8.72% of their stock portfolio, and Lynx1 Capital Management LP now holds 5.45% of the outstanding Cullinan Therapeutics Inc(CGEM) stock.

The initial trade took place in 2023Q2. And since then Lynx1 Capital Management LP has made 5 purchases of CGEM, at an average price of $12.25, for a total of 3.33 Mil shares. In addition, there have been 1 sales at an average price of $10.41 for 115,063.00 shares. Based on historical transaction data and CGEM's current price of $8.33, Lynx1 Capital Management LP's estimated gain on his CGEM holdings is $-12.81 Mil, reflecting a -31.40% gain to date.

Lynx1 Capital Management LP CGEM ($8.33) Holding Chart

Lynx1 Capital Management LP CGEM ($8.33) Quarterly Buys and Sells

Period Bought/Sold (Sh.) % Change Qtr. End Shares Avrg. Price
Shares Bought 0 Average Price $-/Share
Shares Sold 0 Average Price $-/Share
Current Price $0.00 Total Estimated Gain 0 %

Top Ranked Articles

  • 1